文章(zhang)來(lai)源：華潤（集(ji)團）有限公(gong)司 發布時間：2009-08-26
華潤集團(tuan)旗(qi)下三九醫藥(yao)股(gu)(gu)份有限公(gong)(gong)司(si)發布2008年半(ban)年度報告，公(gong)(gong)司(si)實(shi)(shi)現營(ying)業收(shou)入19.10億(yi)元(yuan)，同比增(zeng)(zeng)長(chang)(chang)19.94％；營(ying)業利潤2.77億(yi)元(yuan)，同比增(zeng)(zeng)長(chang)(chang)116.55％；歸屬于母(mu)(mu)公(gong)(gong)司(si)的凈利潤為(wei)2.09億(yi)元(yuan)，同比增(zeng)(zeng)長(chang)(chang)122.95％；實(shi)(shi)現每股(gu)(gu)收(shou)益0.21元(yuan)。公(gong)(gong)告還稱，經(jing)財務(wu)部門初步(bu)測算，預計今年前九個月，實(shi)(shi)現的歸屬于母(mu)(mu)公(gong)(gong)司(si)所有者(zhe)的凈利潤與上年同期相(xiang)比增(zeng)(zeng)長(chang)(chang)100%-150%。
今年(nian)上半(ban)年(nian)，三九醫藥(yao)(yao)股(gu)份公司(si)醫藥(yao)(yao)工業收入同比(bi)增(zeng)(zeng)(zeng)長(chang)23.72%，其中(zhong)OTC銷(xiao)(xiao)售(shou)額同比(bi)增(zeng)(zeng)(zeng)長(chang)14%，中(zhong)藥(yao)(yao)處(chu)方(fang)藥(yao)(yao)銷(xiao)(xiao)售(shou)額同比(bi)增(zeng)(zeng)(zeng)長(chang)50%，抗(kang)生素及原料藥(yao)(yao)銷(xiao)(xiao)售(shou)額同比(bi)增(zeng)(zeng)(zeng)長(chang)66%，延續了較快的增(zeng)(zeng)(zeng)長(chang)勢頭(tou)，免煎中(zhong)藥(yao)(yao)銷(xiao)(xiao)售(shou)額同比(bi)增(zeng)(zeng)(zeng)長(chang)55%。產品(pin)方(fang)面，主(zhu)打產品(pin)感(gan)冒靈(ling)銷(xiao)(xiao)售(shou)同比(bi)增(zeng)(zeng)(zeng)長(chang)26%，達到2.65億元(yuan)；皮炎平軟膏銷(xiao)(xiao)售(shou)達到2.46億元(yuan)，同比(bi)增(zeng)(zeng)(zeng)長(chang)12.60%，參附及生脈銷(xiao)(xiao)售(shou)分別增(zeng)(zeng)(zeng)長(chang)52%及230%，三九皮炎平、三九胃(wei)泰保持平穩(wen)；新產品(pin)小兒感(gan)冒靈(ling)、復方(fang)氨酚(fen)烷胺(an)、無水頭(tou)孢唑林(lin)鈉等增(zeng)(zeng)(zeng)長(chang)快速。